Reduce risk, avoid mistakes and speed up compliance with EU Medical Device Directive (MDD) regulations by completing Device-Drug Combinations: Borderline Issues and Consultation Process Guidance. This one day training course is designed to help device-drug manufacturers prove products are safe for market.
“The tutor undertook the course with enthusiasm, and allowed each group member to provide input into the day.”
If you work with ancillary medical substances or derivatives of human blood or plasma, we can help you remove all uncertainty from the consultation process. We will outline ISO 13485:2003 and EU MDD requirements, allowing you to establish realistic timescales and avoid common errors that can cause delays and working with our experts, you can be confident of ISO 13485:2003 and EU compliance.
The course is recognised by the Medicines and Healthcare products Regulatory Agency.
£800 + VAT
1 day
includes refreshments, lunch and course notes.
Who should attend?
- Those working in regulatory affairs, research and development
- Consultants and project managers
- Anyone involved in the product to market process.
Call our training advisors now
+44 (0)845 086 9000
training@bsigroup.com